|1|Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy. (24414227)
Wu J.... Yu E.
|2|IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. (23075137)
Hart P.A.... Chari S.T.
|3|IGFBP-3 nuclear localization predicts human prostate cancer recurrence. (23011725)
Seligson D.B.... Lee K.W.
|4|Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women. (23528112)
Uzun H.... Kalkan M.
|5|Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer. (22363599)
Sircar K.... Zhang W.
|6|PDEF downregulates stathmin expression in prostate cancer. (22378487)
Sabherwal Y.... Zhang M.
|7|Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. (21940908)
Makhov P.B.... Kolenko V.M.
|8|Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy. (22140573)
Veljkovic M.... Colombatti A.
|9|Prostatitis: predictive value of post-massage urine leukocyte count for AIP. (20145661)
Murphy A.B.... Nadler R.B.
|10|Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. (20541699)
Andersen R.J.... Sadar M.D.
|11|Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. (19215786)
Paz-y-MiA+o C.... ArAcvalo M.
|12|Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. (18451159)
Park S.I.... Gallick G.E.
|13|Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer. (18196513)
Liu J.W.... Sidransky D.
|14|TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. (18163430)
Zhu M.L.... Kyprianou N.
|15|Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice]. (19080439)
Zhang Y.... Liang C.S.
|16|Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. (18384941)
Ummanni R.... Walther R.
|17|Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. (19047104)
Singh R.P.... Agarwal R.
|18|Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro. (18686131)
Sawant R.M.... Rokhlin O.W.
|19|Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. (17317829)
Miyake H.... Fujisawa M.
|20|Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. (17510436)
Mostaghel E.A.... Nelson P.S.
|21|In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. (17440096)
Banerjee S.... Sarkar F.H.
|22|Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. (17242703)
Georgitsi M.... Aaltonen L.A.
|23|Chemoprevention of prostate cancer. Current status]. (17483928)
Schmitz-DrAoger B.J.... SchAofer R.M.
|24|Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression. (16675569)
Ashida S.... Nakagawa H.
|25|Effect of PC-1 gene expression on migration ability of prostate cancer cells]. (16159422)
Zhang H.... Huang C.F.
|26|Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population. (15479493)
Gilligan T.... Kantoff P.W.
|27|Isolation and characterization of human and mouse WDR19,a novel WD- repeat protein exhibiting androgen-regulated expression in prostate epithelium. (12906858)
Lin B.... Nelson P.S.
|28|Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. (14613585)
Banerjee A.G.... Vishwanatha J.K.
|29|Re: Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer. (12771784)
Yashi M.... Tokue A.
|30|New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. (12783936)
Marchesani M.... Salonen J.T.
|31|Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. (12746842)
Brubaker K.D.... Corey E.
|32|Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails. (12686822)
Kassouf W.... Aprikian A.G.
|33|Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. (12915880)
Nakazato H.... Yamanaka H.
|34|Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. (11391602)
Sebo T.J.... Zincke H.
|35|Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? (10620572)
Jung K.... Loening S.A.
|36|IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. (10840462)
Nadler R.B.... Schaeffer A.J.
|37|Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. (10223487)
Darson M.F.... Bostwick D.G.
|38|BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. (10379729)
Scherr D.S.... Knudsen B.S.
|39|Influence of luteinizing hormone-releasing hormone analogues on serum levels of prostatic acid phosphatase and prostatic specific antigen in patients with metastatic carcinoma of the prostate. (10195870)
Sasagawa I.... Adachi M.
|40|Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. (9446667)
Rivas C.I.... Golde D.W.
|41|Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. (9743298)
Lehrer S.... McGovern M.
|42|Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. (9637141)
Cote R.J.... Lieskovosky G.
|43|The effect of dihydrotestosterone on transcription of prostatic acid phosphatase mRNA in human hyperplastic gland. (9584855)
DuliA8ska J.... GaA8ka M.
|44|Secondary mucinous adenocarcinoma of the prostate in a patient with ulcerative colitis. (8389496)
Yamaguchi S.... Yachiku S.
|45|Species differences in 5 alpha-androstane-3 beta,17 beta-diol hydroxylation by rat, monkey, and human prostate microsomes. (1378714)
Gemzik B.... Parkinson A.
|46|Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. (1373581)
Grignon D.J.... Ayala A.G.
|47|Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. (1716536)
Lilja H.... LAPvgren T.
|48|CT features of perirectal fascia thickening after transurethral resection of prostatic adenoma. (2433317)
Parienty R.A.... Veillon B.
|49|Mucinous adenocarcinoma of the prostate. (195095)
Chica G.... Ayala A.G.
|50|Papillomatosis and papillary adenocarcinoma of prostatic ducts: a case report. (5532917)
Belter L.F.... DODSON A.I.